Grants per year
Search results
-
Active
CCSG Senior Leadership
Platanias, L. C. (PD/PI), Abdulkadir, S. A. (Other), Cella, D. (Other), Green, K. J. (Other) & Hussain, M. (Other)
8/1/23 → 7/31/25
Project: Research project
-
Therapeutic targeting of Aurora Kinase A in lethal prostate cancer using a novel inhibitor
Hussain, M. (PD/PI), Fenton, S. E. (Co-Investigator) & Yang, X. J. (Co-Investigator)
Emory University, U.S. Army Medical Research and Materiel Command
7/1/23 → 6/30/26
Project: Research project
-
A Phase 1/2 Open-Label, Dose-Escalation and Cohort Expansion Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARV-766 Monotherapy and in Combination with Abiraterone in Patients with Metastatic Prostate Cancer
Hussain, M. (PD/PI)
Pharmaceutical Research Associates, Inc., Arvinas Androgen Receptor, Inc.
6/1/23 → 6/1/26
Project: Research project
-
Prot #GLSI-21-01: A Randomized, Multicenter, Placebo-controlled, Phase 3 study to Evaluate the Efficacy and Safety of HER2/neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/neu Positive Subjects with Residual Disease or High-Risk PCR after both Neoadjuvant and
Hussain, M. (PD/PI)
5/31/23 → 5/31/26
Project: Research project
-
Tactical Approaches to Repress oncogenic Gene Expression in prostatic Tumors (TARGET)
Abdulkadir, S. A. (PD/PI), Abdulkadir, S. A. (PD/PI), Fenton, S. E. (Co-Investigator), Fenton, S. E. (Co-Investigator), Hussain, M. (Co-Investigator), Hussain, M. (Co-Investigator), Schiltz, G. E. (Co-Investigator) & Schiltz, G. E. (Co-Investigator)
University of Michigan, Prostate Cancer Foundation
2/10/23 → 2/9/26
Project: Research project
-
Enhanced Targeting of CBP/p300 in a Subtype of Metastatic Prostate Cancer
Yu, J. (PD/PI), Yu, J. (PD/PI), Hussain, M. (Co-Investigator), Hussain, M. (Co-Investigator), Yang, X. J. (Co-Investigator), Yang, X. J. (Co-Investigator), Zhao, C. (Co-Investigator) & Zhao, C. (Co-Investigator)
U.S. Army Medical Research and Materiel Command
4/1/22 → 3/31/25
Project: Research project
-
SPORE in Prostate Cancer
Abdulkadir, S. A. (PD/PI), Abdulkadir, S. A. (PD/PI), Hussain, M. (Co-PD/PI), Hussain, M. (Co-PD/PI), Catalona, W. J. (Co-Investigator), Catalona, W. J. (Co-Investigator), Chakravarti, D. (Co-Investigator), Chakravarti, D. (Co-Investigator), Cooper, L. A. D. (Co-Investigator), Kim, K.-Y. A. (Co-Investigator), Kim, K.-Y. A. (Co-Investigator), Kim, K.-Y. A. (Co-Investigator), Morgans, A. K. (Co-Investigator), Morgans, A. K. (Co-Investigator), Murphy, A. B. (Co-Investigator), Murphy, A. B. (Co-Investigator), Ross, A. E. (Co-Investigator), Schiltz, G. E. (Co-Investigator), Schiltz, G. E. (Co-Investigator), VanderWeele, D. J. (Co-Investigator), Wei, J.-J. (Co-Investigator), Wei, J.-J. (Co-Investigator), Yang, R. (Co-Investigator), Yang, R. (Co-Investigator), Yu, J. (Co-Investigator), Yu, J. (Co-Investigator), Kocherginsky, M. (Other), Kocherginsky, M. (Other), Leikin, R. G. (Other), Leikin, R. G. (Other), Sosman, J. A. (Other), Sosman, J. A. (Other), Wu, J. D. (Other), Wu, J. D. (Other), Yang, X. J. (Other), Yang, X. J. (Other), Yang, R. (Other), Zhao, C. (Other) & Zhao, C. (Other)
9/1/21 → 7/31/26
Project: Research project
-
Prot #ARV-110-mCRPC-101: A Phase 1/2, Open-label, Dose Escalation and Cohort Expansion Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARV-110 in Patients with Metastatic Castration-resistant Prostate Cancer
Hussain, M. (PD/PI)
Novella Clinical, LLC, Arvinas Androgen Receptor, Inc.
7/31/20 → 7/31/26
Project: Research project
-
SWOG NCORP Accrual Site
Hussain, M. (PD/PI) & Hussain, M. (PD/PI)
Oregon Health and Science University, National Cancer Institute
8/1/19 → 7/31/25
Project: Research project
-
SWOG Network Group Operations Center of the NCTN
Hussain, M. (PD/PI) & Hussain, M. (PD/PI)
Oregon Health and Science University, National Cancer Institute
3/1/19 → 2/28/25
Project: Research project
-
Therapy Consortium Award
Hussain, M. (PD/PI) & Hussain, M. (PD/PI)
5/1/17 → 12/21/25
Project: Research project
-
Prot #c16-168: A Randomized Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients with Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects
Hussain, M. (PD/PI)
Prostate Cancer Clinical Trials Consortium, LLC, AstraZeneca Pharmaceuticals LP
11/11/16 → 11/11/25
Project: Research project
-
SWOG Clinical Trials Initiative Purchased Service Agreement
Hussain, M. (PD/PI) & Hussain, M. (PD/PI)
SWOG - Clinical Trials Initiative LLC
10/1/14 → 8/31/25
Project: Research project
-
Finished
The Robert H. Lurie Comprehensive Cancer Center
Platanias, L. C. (PD/PI), Arispe, L. (Co-Investigator), Arvanitis, C. (Co-Investigator), Bonini, M. (Co-Investigator), Butt, Z. (Co-Investigator), Kocherginsky, M. (Co-Investigator), Kumthekar, P. U. (Co-Investigator), Rini, C. (Co-Investigator), Shilatifard, A. (Co-Investigator), Wignall, S. (Co-Investigator), Zhang, Z. (Co-Investigator), Agulnik, M. (Other), Awatramani, R. (Other), Backman, V. (Other), Benson III, A. B. (Other), Carthew, R. W. (Other), Cella, D. (Other), Chakravarti, D. (Other), Chandel, N. (Other), Crispino, J. D. (Other), Cristofanilli, M. (Other), Eklund, E. A. (Other), Frankfurt, O. (Other), Gordon, L. I. (Other), Green, K. J. (Other), Hahn, E. A. (Other), Hitsman, B. L. (Other), Horbinski, C. M. (Other), Horvath, C. M. (Other), Hussain, M. (Other), James, C. D. (Other), Kelleher, N. L. (Other), Khan, S. A. (Other), LaBonne, C. (Other), Larson, A. C. (Other), Matei, D. E. (Other), Meade, T. J. (Other), Mondragon, A. (Other), Mrksich, M. (Other), Munshi, H. G. (Other), Murphy, A. B. (Other), Obeng, R. (Other), Penedo, F. J. (Other), Perlman, H. R. (Other), Peter, M. E. (Other), Rademaker, A. W. (Other), Rappoport, J. Z. (Other), Rosenzweig, A. C. (Other), Scheidt, K. A. (Other), Simon, M. A. (Other), Sosman, J. A. (Other), Spring, B. (Other), Wei, J.-J. (Other), Weiss, E. L. (Other) & Woloschak, G. E. (Other)
8/10/18 → 7/31/23
Project: Research project
-
Targeting chemokine signaling and MAPK/ERK pathway in advanced prostate cancer
Yu, J. (PD/PI), Cristofanilli, M. (Co-Investigator), Hussain, M. (Co-Investigator), Miller, R. J. (Co-Investigator), Schiltz, G. E. (Co-Investigator), Yang, X. J. (Co-Investigator), Zhang, B. (Co-Investigator) & Zhao, C. (Co-Investigator)
12/31/17 → 2/28/23
Project: Research project
-
Clinical, Environmental, Genetic and Genomic profile of Men with Early Onset Lethal Prostate Cancer
Hussain, M. (PD/PI), Hussain, M. (PD/PI), Abdulkadir, S. A. (Co-Investigator), Abdulkadir, S. A. (Co-Investigator), Jovanovic, B. (Co-Investigator), Jovanovic, B. (Co-Investigator), Meeks, J. J. (Co-Investigator), Meeks, J. J. (Co-Investigator), Morgans, A. K. (Co-Investigator), Morgans, A. K. (Co-Investigator), Schaeffer, E. M. (Co-Investigator) & Schaeffer, E. M. (Co-Investigator)
12/31/17 → 12/31/24
Project: Research project
-
A Phase III, Open Label, Randomized Study to Assess the Efficacy and Safety of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men with Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment with a New Hormonal
Hussain, M. (PD/PI)
AstraZeneca Pharmaceuticals LP
9/26/17 → 1/1/21
Project: Research project
-
Prot #2003376607: NU JH17U01: Overcoming drug resistance in metastatic castration-resistant prostate cancer with novel combination of TGF-ß receptor inhibitor LY2157299 and enzalutamide: a randomized multi-site phase II study
Hussain, M. (PD/PI) & Morgans, A. K. (PD/PI)
9/1/17 → 12/31/24
Project: Research project
-
Prot #BAY1841788/17777: A Randomized, Double-Blind, Placebo-Controlled Phase III Study of ODM-201 Versus Placebo in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Patients with Metastatic Hormone-Sensitive Prostate Cancer
Hussain, M. (PD/PI)
Covance Inc., Bayer HealthCare Pharmaceuticals, Inc.
5/16/17 → 4/1/24
Project: Research project
-
Prot #D081DC00007: A Phase III, Open Label, Randomized Study to Assess the Efficacy and Safety of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men with Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment w
Hussain, M. (PD/PI)
Covance Inc., AstraZeneca Pharmaceuticals LP
4/7/17 → 4/7/20
Project: Research project
-
Prot #WO29636: A Phase III, Open-Label, Multicenter, Randomized Study of Atezolizumab (Anti-PD-L1 Antibody) versus Observation as Adjuvant Therapy in Patients with High-Risk Muscle-Invasive Urothelial Carcinoma after Surgical Resection
Hussain, M. (PD/PI)
INC Research, LLC, Genentech, Inc
1/10/17 → 1/10/23
Project: Research project
-
Prot #145515: NU UCSF15U05: A Phase 1b/2 Study of the Oral CDK4/6 Inhibitor LEE011 (Ribociclib) in Combination with Docetaxel plus Prednisone in Metastatic Castration Resistant Prostate Cancer
Carneiro Filho, B. A. (PD/PI) & Hussain, M. (PD/PI)
Prostate Cancer Clinical Trials Consortium, LLC, Novartis Pharmaceuticals Corporation
5/25/16 → 12/31/18
Project: Research project
-
SWOG Purchase Service Agreement-OHSU
Giles, F. J. (PD/PI) & Hussain, M. (PD/PI)
Oregon Health and Science University, National Cancer Institute
9/14/15 → 8/31/23
Project: Research project